MR-78

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameMR-78
Drug Alias NameMR-78
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionNPC Intracellular Cholesterol Transporter 1 inhibitors
TargetsNPC Intracellular Cholesterol Transporter 1
Therapy Area/IndicationsMarburg Virus DiseaseHemorrhagic Fever, Ebola
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe Scripps Research Institute Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity of TorontoKyushu UniversityThe Scripps Research Institute Inc +[4] 
Active IndicationsN/A
Inactive IndicationsMarburg Virus DiseaseHemorrhagic Fever, Ebola

Other Information

ATC CodeN/A
Related LinksN/A